µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
½Å°æ±Ù°è °ü·Ã ¾à¹°(Neuro-Muscular System Related Agents)
  ±âŸ ½Å°æ±Ù°è ¾à¹°(Other Neuromuscular System)
  Neostigmine Methylsulfate 500g
 
°Ë»öµÈ Á¦Ç°¸í (À¯ÅëÁßÀÎ Á¦Ç°) ÃÑ 2°³
´ëÁ¶¾à:¡Ü »ýµ¿¼º½ÃÇè¿Ï·á:¡Ü ºñ±³¿ëÃâ½ÃÇè¿Ï·á:¡Ü
Á¦Ç°¸í ÆÇ¸Å»ç ±¸ºÐ º¸Çè º¸Çè°¡ ´ëü
´ëÇѳ׿À½ºÆ¼±×¹Î¸ÞƿȲ»ê¿°ÁÖ»ç¾× 1mL´ëÇѾàÇ°°ø¾÷(ÁÖ)Àü¹®±Þ¿©300 ¿ø 
Á¦ÀÏÁ¦¾à³×¿À½ºÆ¼±×¹Î¸ÞƿȲ»ê¿°ÁÖ(ÁÖ)Á¦ÀÏÁ¦¾àÀü¹®±Þ¿©300 ¿ø 
[1]
»èÁ¦.¹Ì»ý»ê Á¦Ç° (À¯ÅëµÇÁö ¾ÊÀº Á¦Ç°) ÃÑ 9°³
Á¦Ç°¸í ÆÇ¸Å»ç ±¸ºÐ »ý»ê¿©ºÎ
³×¿À½º¹ÎÁÖ»ç(¸ÞĥȲ»ê³×¿À½ºÆ¼±×¹Î)ÇϳªÁ¦¾à(ÁÖ)Àü¹® 
³×¿À½ºÁÖ(¸ÞĥȲ»ê³×¿À½ºÆ¼±×¹Î)Çѱ¹ÄÚ·¯½º(ÁÖ)Àü¹® 
³×Ƽ¹ÎÁÖÇѱ¹À¯´Ï¿ÂÁ¦¾à(ÁÖ)Àü¹® 
´ëÇѸÞĥȲ»ê³×¿À½ºÆ¼±×¹ÎÁÖ»ç¾×´ëÇѾàÇ°°ø¾÷(ÁÖ)Àü¹® 
´ëÈ­¸ÞĥȲ»ê³×¿À½ºÆ¼±×¹ÎÁÖ´ëÈ­Á¦¾à(ÁÖ)Àü¹® 
½ºÆ¼±¸¹ÎÁÖ(¸ÞĥȲ»ê³×¿À½ºÆ¼±×¹Î)¾ÆÁÖ¾àÇ°(ÁÖ)Àü¹® 
Á¦ÀÏÁ¦¾à³×¿À½ºÆ¼±×¹Î¸ÞƿȲ»ê¿°ÁÖ(ÁÖ)Á¦ÀÏÁ¦¾àÀü¹® 
Áê¹Ù½º¹ÎÁÖ»ç¾×(¸ÞĥȲ»ê³×¿À½ºÆ¼±×¹Î)(ÁÖ)È޿½ºÀü¹® 
ÇѼ­¸ÞĥȲ»ê³×¿À½ºÆ¼±×¹ÎÁÖ»ç¾×(ÁÖ)¼¿Æ®¸®¿ÂÁ¦¾àÀü¹® 
[1]
 
ºñÆ®µå·¯±×ÀÎÆ÷